PharmaNutra dividend and valuation
Valuation
PharmaNutra paid €1.20 per share in dividends over the last 12 months (yield 1.4%). Last ex-dividend date: May 4, 2026. The P/E ratio is 35.0. The average price target of 3 analysts is €96.00.
What would PharmaNutra's dividends pay over 10 years? Work it out with the dividend calculator
Data as of November 16, 2026
PharmaNutra compared with similar companies
PharmaNutra's P/E (trailing 12 months): 35.0, +86% against the median of a group of 9 similar companies (18.8).
| Metric | PharmaNutra | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 35.0 | 18.8 | 17.4 – 25.5 | High |
| Forward P/E | 25.2 | 17.9 | 14.6 – 22.2 | High |
| EV/EBITDA | 21.7 | 12.3 | 8.98 – 15.2 | High |
| Price/book | 10.4 | 2.77 | 1.76 – 3.31 | High |
| Price/sales | 5.34 | 2.20 | 2.00 – 4.02 | High |
| Gross margin | 48.2% | 65.2% | 35.7% – 77.1% | Middle |
| Operating margin | 21.7% | 16.7% | 11.3% – 23.1% | Middle |
| Net margin | 15.4% | 11.9% | 7.0% – 15.5% | Middle |
| ROE | 32.4% | 15.4% | 7.6% – 16.8% | High |
| Debt/equity | 0.26 | 0.33 | 0.22 – 0.71 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
PharmaNutra: valuation over time
On the latest fiscal year's earnings (2025), PharmaNutra's P/E today is 41.5, above the median of its last 9 fiscal years (26.8; between 17.1 and 53.0 from 2017 to 2025). Relative to earnings, the stock costs more than it used to. The dividend yield (1.4%) is below the median of the last 9 fiscal years (1.8%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| 2025 | €54.30 | €2.09 | 26.0 | €1.20 | 2.2% |
| 2024 | €54.40 | €1.73 | 31.5 | €1.00 | 1.8% |
| 2023 | €56.40 | €1.33 | 42.5 | €0.85 | 1.5% |
| 2022 | €62.30 | €1.56 | 40.0 | €0.80 | 1.3% |
| 2021 | €75.40 | €1.42 | 53.0 | €0.71 | 0.9% |
| 2020 | €37.60 | €1.45 | 25.9 | €0.67 | 1.8% |
| 2019 | €23.40 | €0.87 | 26.8 | €0.46 | 2.0% |
| 2018 | €15.10 | €0.88 | 17.1 | €0.42 | 2.8% |
| 2017 | €12.70 | €0.62 | 20.4 | €0.33 | 2.6% |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- €796.66M
- Enterprise value
- €784.5M
- EV/revenue
- 5.25
Profitability and growth
- ROA
- 16.2%
- ROIC
- 22.4%
- Revenue growth (year over year)
- 19.3%
- Earnings growth (year over year)
- 48.1%
Financial health
- Total cash
- €25.12M
- Total debt
- €20.02M
- Current ratio
- 2.11
- Quick ratio
- 1.58
- Altman Z-Score
- 9.86
- Piotroski F-Score
- 5.00
Dividends
- Annual dividend per share
- €1.20
- Dividend yield
- 1.4%
- Payout ratio
- 50.4%
- Ex-dividend date
- May 4, 2026
Analysts and estimates
- Average price target
- €96.00
- Median price target
- €93.00
- High price target
- €103.00
- Low price target
- €92.00
- Analysts with a price target
- 3
- Consensus
- Strong buy
- Forward EPS
- €3.31
- EPS estimate, current year
- €2.59
Shares and trading
- Beta
- 0.20
- Average volume
- 15.17K
- Shares outstanding
- 9.58M
- Float
- 3.24M
- Institutional ownership
- 15.0%
- Insider ownership
- 65.0%
